JP2023548429A5 - - Google Patents
Info
- Publication number
- JP2023548429A5 JP2023548429A5 JP2023550714A JP2023550714A JP2023548429A5 JP 2023548429 A5 JP2023548429 A5 JP 2023548429A5 JP 2023550714 A JP2023550714 A JP 2023550714A JP 2023550714 A JP2023550714 A JP 2023550714A JP 2023548429 A5 JP2023548429 A5 JP 2023548429A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20206645 | 2020-11-10 | ||
| EP20206645.2 | 2020-11-10 | ||
| PCT/EP2021/081162 WO2022101227A1 (en) | 2020-11-10 | 2021-11-09 | [2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine (mesdopetam) for use in the prevention or reduction of sensitization to a pharmaceutical drug for parkinson's disease, in particular l-dopa induced dyskinesias |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023548429A JP2023548429A (ja) | 2023-11-16 |
| JP2023548429A5 true JP2023548429A5 (https=) | 2024-11-18 |
| JPWO2022101227A5 JPWO2022101227A5 (https=) | 2024-11-18 |
Family
ID=73288427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023550714A Abandoned JP2023548429A (ja) | 2020-11-10 | 2021-11-09 | パーキンソン病、特にｌ－ｄｏｐａ誘発性ジスキネジアのための医薬品に対する感作の予防または軽減における使用のための［２－（３－フルオロ－５－メタンスルホニルフェノキシ）エチル］（プロピル）アミン（メスドペタム） |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20220168242A1 (https=) |
| EP (1) | EP4243801A1 (https=) |
| JP (1) | JP2023548429A (https=) |
| KR (1) | KR20230106659A (https=) |
| CN (1) | CN116685314A (https=) |
| AR (1) | AR124036A1 (https=) |
| AU (1) | AU2021378472A1 (https=) |
| CA (1) | CA3198266A1 (https=) |
| TW (1) | TW202233169A (https=) |
| WO (1) | WO2022101227A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024062344A1 (en) * | 2022-09-21 | 2024-03-28 | Assia Chemical Industries Ltd. | Solid state forms of mesdopetam and salts therof |
| GB202312055D0 (en) | 2023-08-07 | 2023-09-20 | Ipsen Biopharm Ltd | Pharmaceutical compositions |
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080036957A (ko) | 2005-06-23 | 2008-04-29 | 아스트라제네카 아베 | 위장 질환 치료용 뉴로키닌 수용체 길항제로서의 신규한아제티딘 유도체 |
| CN103347517B (zh) * | 2010-08-11 | 2018-10-02 | 德雷克塞尔大学 | 治疗帕金森病中运动障碍的d3多巴胺受体激动剂 |
| EP2699543B1 (en) | 2011-04-19 | 2016-03-02 | Integrative Research Laboratories Sweden AB | Novel modulators of cortical dopaminergic- and nmda-receptor-mediated glutamatergic neurotransmission |
| EP2858649B1 (en) * | 2012-06-11 | 2019-10-23 | Psychogenics Inc. | Treatment of motor and movement disorder side effects associated with parkinson's disease treatments |
| ES2869981T3 (es) * | 2015-05-26 | 2021-10-26 | Technophage Investig E Desenvolvimento Em Biotecnologia Sa | Composiciones para su uso en el tratamiento de la enfermedad de parkinson y trastornos relacionados |
| WO2020110128A1 (en) * | 2018-11-29 | 2020-06-04 | Prilenia Neurotherapeutics Ltd. | Combination of pridopidine and an additional therapeutic agent for treating drug induced dyskinesia |
| FI3976581T3 (fi) * | 2019-05-24 | 2024-01-31 | Irl 790 Ab | [2-(3-fluori-5-metaani-sulfonyylifenoksi)etyyli](propyli)amiinin viinihapposuolat |
-
2021
- 2021-11-09 CN CN202180089407.4A patent/CN116685314A/zh active Pending
- 2021-11-09 AU AU2021378472A patent/AU2021378472A1/en not_active Abandoned
- 2021-11-09 WO PCT/EP2021/081162 patent/WO2022101227A1/en not_active Ceased
- 2021-11-09 JP JP2023550714A patent/JP2023548429A/ja not_active Abandoned
- 2021-11-09 US US17/454,110 patent/US20220168242A1/en not_active Abandoned
- 2021-11-09 CA CA3198266A patent/CA3198266A1/en active Pending
- 2021-11-09 TW TW110141661A patent/TW202233169A/zh unknown
- 2021-11-09 EP EP21799308.8A patent/EP4243801A1/en active Pending
- 2021-11-09 KR KR1020237019294A patent/KR20230106659A/ko active Pending
- 2021-11-09 AR ARP210103113A patent/AR124036A1/es not_active Application Discontinuation
-
2023
- 2023-09-06 US US18/461,791 patent/US20240148674A1/en not_active Abandoned